Biblio
Export 292 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is S [Clear All Filters]
“Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.”, J Alzheimers Dis, vol. 83, no. 1, pp. 23-41, 2021.
, “Serum Copper is not Altered in Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1427-1432, 2018.
, “Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?”, J Alzheimers Dis, vol. 56, no. 3, pp. 1055-1064, 2017.
, “Reduced Gray Matter Volume of the Thalamus and Hippocampal Region in Elderly Healthy Adults with no Impact of APOE ɛ4: A Longitudinal Voxel-Based Morphometry Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 757-771, 2018.
, “Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 223-42, 2016.
, “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.
, “Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”, Alzheimers Dement, vol. 7, no. 3, pp. 280-92, 2011.
, “The Relationship Between Cardiovascular Health and Rate of Cognitive Decline in Young-Old and Old-Old Adults: A Population-Based Study.”, J Alzheimers Dis, vol. 84, no. 4, pp. 1523-1537, 2021.
, “Accelerometer-Measured, Habitual Physical Activity and Circulating Brain-Derived Neurotrophic Factor: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 85, no. 2, pp. 805-814, 2021.
, “Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 3, pp. 807-16, 2016.
, “Do Microglia Default on Network Maintenance in Alzheimer's Disease?”, J Alzheimers Dis, vol. 51, no. 3, pp. 657-69, 2016.
, “Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor.”, J Alzheimers Dis, 2020.
, “Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1225-1231, 2023.
, “Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
, “Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1539-1548, 2018.
, “An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1639-1653, 2020.
, “Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 66, no. 2, pp. 497-515, 2018.
, “A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway.”, J Alzheimers Dis, vol. 51, no. 2, pp. 591-604, 2016.
, “Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1197-208, 2016.
, “A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.”, J Alzheimers Dis, vol. 54, no. 1, pp. 383-95, 2016.
, “Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review.”, J Alzheimers Dis, vol. 64, no. s1, pp. S229-S254, 2018.
, “Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.”, J Alzheimers Dis, vol. 59, no. 3, pp. 815-849, 2017.
, “Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1015-1021, 2021.
, “Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 229-237, 2017.
, “Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 137-145, 2018.
,